SCHEMBL20249678

SCHEMBL20249678

Cc1c2c(-c3cccc(-c4ccncc4)c3)nc3ccccc3c2c(C)c2c(-c3cccc(-c4ccncc4)c3)nc3ccccc3c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 4/20 0.42
NOTUM Q6P988 1/20 0.42
MAPK13 O15264 2/20 0.41
MAPK12 P53778 2/20 0.41
MAPK11 Q15759 2/20 0.41
MAPK14 Q16539 2/20 0.41
GCGR P47871 1/20 0.41
MAPT P10636 6/20 0.41
KDM4E B2RXH2 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 2/20 0.41
LMNA P02545 2/20 0.41
RECQL P46063 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
PDE10A Q9Y233 2/20 0.40
TSHR P16473 1/20 0.40
MKNK1 Q9BUB5 1/20 0.40
RIPK3 Q9Y572 1/20 0.40
HSP90AA1 P07900 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20249629 0.90 DHODH (0.44) DHODHMAPK13MAPK12MAPK11MAPK14
SCHEMBL20245110 0.89 DHODH (0.46) DHODHMAPK13MAPK12MAPK11MAPK14
SCHEMBL20245041 0.89 DHODH (0.46) DHODHMAPK13MAPK12MAPK11MAPK14
SCHEMBL20249642 0.88 DHODH (0.49) DHODHNOTUMMAPK13MAPK12MAPK11
SCHEMBL20249681 0.86 CYP1A2 (0.44) DHODHMAPTKDM4EMEN1KMT2A
SCHEMBL20245140 0.86 DHODH (0.43) DHODHMAPK14MAPTMEN1KMT2A
SCHEMBL20249662 0.86 MKNK1 (0.47) DHODHNOTUMMAPK13MAPK12MAPK11
SCHEMBL17914765 0.86 NOTUM (0.44) DHODHNOTUMMAPK13MAPK12MAPK11
SCHEMBL20245131 0.85 MAPT (0.42) DHODHMAPK14MAPTKDM4EMEN1
SCHEMBL20249686 0.85 MEN1 (0.43) DHODHMAPK14MAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3333168-B1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2022-01-26 EP disclosed
US-10693083-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-06-23 US disclosed
US-20180166635-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-14 US disclosed
US-20180166635-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180166635-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 DHODH 1907/4885NOTUM 1888/4885MAPK13 4090/4885
US-10693083-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 DHODH 1907/4885NOTUM 1888/4885MAPK13 4090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.